Premium
Peritoneovenous shunt for intractable malignant ascites. A single case report of metastatic peritoneal mesothelioma implanted via leveen shunt
Author(s) -
Nervino Harry E.,
Gebhardt Fred C.
Publication year - 1984
Publication title -
cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.052
H-Index - 304
eISSN - 1097-0142
pISSN - 0008-543X
DOI - 10.1002/1097-0142(19841115)54:10<2231::aid-cncr2820541027>3.0.co;2-i
Subject(s) - medicine , peritoneovenous shunt , ascites , surgery , shunt (medical) , vomiting , carboplatin , contraindication , chemotherapy , pathology , alternative medicine , cisplatin
A patient with malignant ascites refractory to conservative and conventional therapy underwent peritoneovenous shunt. The shunt provided palliation for 7 months with relief of nausea, vomiting, and anorexia and with decrease of weight and abdominal girth. There was no need for repeated paracenteses, which had been required before shunting. The patienťs strength increased. However, increasing shortness of breath developed approximately 6 to 7 months after insertion of the shunt. The shunt was associated with extensive metastatic dissemination of peritoneal mesothelioma to both lungs. It is suggested that peritoneal mesothelioma is a contraindication for peritoneovenous shunt.